The carboxy-terminal domain of IGF-binding protein-5 inhibits heparin binding to a site in the central domain

Journal of Molecular Endocrinology

Volumn 26, Issue 3, 2001, Pages 229-239

  Song, H ^a   Shand, J H ^a   Beattie, J ^a   Flint, D J ^a   Allan, G J ^a  

^a HANNAH RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; HEPARIN; MUTANT PROTEIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 5;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; BIOSENSOR; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN;

ANIMALS; BASE SEQUENCE; BINDING SITES; BLOTTING, WESTERN; DNA PRIMERS; HEPARIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; RATS;

EID: 0034990595     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0260229     Document Type: Article

References (31)

1. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action
2. Carboxytruncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells
3. Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes
4. Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I response to heparin
5. IGFBP-3 and IGFBP-5 association with endothelial cells: Role of C-terminal heparin binding domain
6. IGFBP-3 proteolysis by plasmin, thrombin, serum: Heparin binding, IGF binding, and structure of fragments
7. Amino acids within the extracellular matrix (ECM) binding region (201-218) of rat insulin-like growth factor binding protein (IGFBP)-5 are important determinants in binding IGF-I
8. Insulin-like growth factor-I receptor signal transduction: At the interface between physiology and cell biology
9. Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). Localization of cleavage site to non-homologous region of native IGFBP-4
10. Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells
11. Cleavage analysis of insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis and expression of protease-resistant IGF-binding protein-4 mutants
12. Phosphorylation of insulin-like growth factor binding proteins
13. Somatomedin: Proposed designation for sulphation factor
14. Ligand blot analysis of insulin-like growth factor-binding proteins using biotinylated insulin-like growth factor-I
15. Binding sites and binding properties of binary and ternary complexes of insulin-like growth factor-II (IGF-II), IGF-binding protein-3, and acid-labile subunit
16. Glycosaminoglycan binding characteristics of the insulin-like growth factor-binding proteins
17. The insulin-like growth factor-binding protein (IGFBP) superfamily
18. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture
19. Extracellular matrix contains insulin-like growth factor binding protein-5: Potentiation of the effects of IGF-I
20. Molecular cloning of a new human insulin-like growth factor binding protein
21. Identification and molecular cloning of two new 30-kDa insulin-like growth factor binding proteins isolated from adult human serum
22. Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast
23. Sequence comparison and predicted structure for the four exon-encoded regions of human insulin-like growth factor binding protein 4
24. Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein-5
25. Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I
26. Effects and fate of human IGF-binding protein-5 in rat osteoblast cultures
27. Overlap of IGF- and heparin-binding sites in rat IGF-binding protein-5
28. Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation
29. Insulin-like growth factor-binding protein 5 complexes with the acid-labile subunit. Role of the carboxyl-terminal domain
30. A central domain binding site in insulin-like growth factor binding protein-5 for the acid-labile subunit
31. Insulin-like growth factor-binding protein-5 is cleaved by physiological concentrations of thrombin